The Islamic Republic of Pakistan became an Associate Member of CERN. This follows notification that Pakistan has ratified an agreement signed in December, granting that status to the country.
Facilities are in place for early stage clinical trials but most are based in universities or hospitals, and commercial scale manufacturing is yet to come on-stream
Oxitec’s technology for combatting dengue fever by releasing sterile mosquitoes into the wild will be applied to other insect-borne diseases by new owner Intrexon
The first paper describing this now world-leading class of therapeutics was published in August 1985. Since then, the UK Medical Research Council has received more than £580M in royalties
EU membership is overwhelmingly positive for our institutes say university heads, as new campaign to protect £1.2B per annum of European research funding gets into gear this week
Martin Rees, UK Astronomer Royal tells Science|Business why it is important to bring entrepreneurial cash and the principles of open innovation to bear on one of the biggest questions in science: Are we alone?
The European Strategy and Policy Analysis System (ESPAS) will continue its mission under new leadership, with plans to increase its global standing in policy analysis and foresight
An innovative new Consortium will act as a ‘match-making’ service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.